Evidence map›Paper›PMID 41004622›Full record

ArticleJournal of bacteriology2025

Adaptation to cinnamaldehyde shapes

Eline Dubois, Susie Gaillot, Benoît Valot, Maxime Bour, Jean-Michel Brunel, Lison Schmidlin, Patrick Plésiat, Catherine Llanes

Abstract read
In one paragraph

Article in Journal of bacteriology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eline DuboisUniversité Marie et Louis Pasteur, CNRS, Chrono-environnement (UMR 6249), Besançon, France.
Susie GaillotUniversité Marie et Louis Pasteur, CNRS, Chrono-environnement (UMR 6249), Besançon, France.
Benoît ValotUniversité Marie et Louis Pasteur, CNRS, Chrono-environnement (UMR 6249), Besançon, France.
Maxime BourCentre National de Référence de la Résistance aux Antibiotiques, Laboratoire de Bactériologie, Centre Hospitalier Universitaire Jean Minjoz, Besançon, France.
Jean-Michel BrunelUMR_MD1, U-1261, Aix Marseille Université, INSERM, SSA, MCT, Marseille, France.
Lison SchmidlinUniversité Marie et Louis Pasteur, CNRS, Chrono-environnement (UMR 6249), Besançon, France.
Patrick PlésiatUniversité Marie et Louis Pasteur, CNRS, Chrono-environnement (UMR 6249), Besançon, France.ORCID 0000-0001-7381-5671
Catherine LlanesUniversité Marie et Louis Pasteur, CNRS, Chrono-environnement (UMR 6249), Besançon, France.ORCID 0000-0001-9671-9084

Funding

Centre de Recherche Pseudomonas 2024French cystic fibrosis associations Vaincre la Mucoviscidose and Gregory Lemarchal RF20200502712Region Bourgogne Franche-Comte 2018Y-04631
6 · The paper itself

Abstract

In France, the use of essential oils to treat bacterial infections is common, with approximately 40% of cystic fibrosis patients regularly using these natural products to control infections caused by

Indexed as

AcroleinAnti-Bacterial AgentsDrug Resistance, BacterialPseudomonas aeruginosaAdaptation, PhysiologicalAminoglycosidesBacterial ProteinsColistinMembrane Transport ProteinsMicrobial Sensitivity TestsMutationAcroleinAminoglycosidesAnti-Bacterial AgentsBacterial ProteinscinnamaldehydeColistinMembrane Transport Proteinsantibiotic resistanceATP synthasecinnamaldehydeefflux pumpsPseudomonas aeruginosa

Identifiers

PMID41004622
PMCPMC12548396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.